Human Metabolome Technologies Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Human Metabolome Technologies has a total shareholder equity of ¥1.9B and total debt of ¥200.0M, which brings its debt-to-equity ratio to 10.3%. Its total assets and total liabilities are ¥2.6B and ¥658.0M respectively. Human Metabolome Technologies's EBIT is ¥220.0M making its interest coverage ratio 110. It has cash and short-term investments of ¥1.8B.
Anahtar bilgiler
10.3%
Borç/özkaynak oranı
JP¥200.00m
Borç
| Faiz karşılama oranı | 110x |
| Nakit | JP¥1.79b |
| Eşitlik | JP¥1.95b |
| Toplam yükümlülükler | JP¥658.00m |
| Toplam varlıklar | JP¥2.60b |
Son finansal sağlık güncellemeleri
Recent updates
Human Metabolome Technologies' (TSE:6090) Weak Earnings May Only Reveal A Part Of The Whole Picture
Oct 03
Human Metabolome Technologies, Inc.'s (TSE:6090) Business And Shares Still Trailing The Market
Aug 06Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00
Jun 07Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00
May 22Human Metabolome Technologies (TSE:6090) Is Paying Out A Larger Dividend Than Last Year
Apr 06Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00
Mar 23Human Metabolome Technologies (TSE:6090) Will Pay A Larger Dividend Than Last Year At ¥15.00
Feb 26Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 6090's short term assets (¥2.1B) exceed its short term liabilities (¥632.0M).
Uzun Vadeli Yükümlülükler: 6090's short term assets (¥2.1B) exceed its long term liabilities (¥26.0M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 6090 has more cash than its total debt.
Borcun Azaltılması: 6090's debt to equity ratio has increased from 0% to 10.3% over the past 5 years.
Borç Kapsamı: 6090's debt is well covered by operating cash flow (118%).
Faiz Kapsamı: 6090's interest payments on its debt are well covered by EBIT (110x coverage).